Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Zhang, Haiyan  [Clear All Filters]
Journal Article
Lu L, Zhu J, Zhang H, Li X, Chen K. Advances in the Pharmacological Intervention of Endothelial Progenitor Cells in the Treatment of Ischemic Stroke. Cerebrovasc Dis. 2022:1-9.
Han X, Li W, He X, Lu X, Zhang Y, Li Y, Bi G, Ma X, Huang X, Bai R, et al. Blockade of TGF-β signalling alleviates human adipose stem cell senescence induced by native ECM in obesity visceral white adipose tissue. Stem Cell Res Ther. 2023;14(1):291.
Li H, Li D, He Z, Fan J, Li Q, Liu X, Guo P, Zhang H, Chen S, Li Q, et al. The effects of Nrf2 knockout on regulation of benzene-induced mouse hematotoxicity. Toxicol Appl Pharmacol. 2018.
Zhang H, Ma Y, Yan B, Yang X, Li Y, Guan J, Dong R, Liu Y, Gai Z. Establishment of a human induced pluripotent stem cell line (SDQLCHi005-A) from a patient with mastocytosis carrying heterozygous mutation in KIT gene. Stem Cell Res. 2019;40:101565.
Wang B, Yang L, Gao M, Zhang H, Liu Y, Gai Z. Establishment of a human induced pluripotent stem cell line（SDQLCHi059-A）from a patient with congenital disorder of glycosylation carrying heterozygous mutation in MPI gene. Stem Cell Res. 2024;77:103381.
Wang B, Yang L, Li Y, Gao M, Zhang H, Yang X, Guan J, Liu Y, Gai Z. Establishment of a human induced pluripotent stem cell line (SDQLCHi037-A) from a patient with Alagille syndrome carrying heterozygous mutation in JAG1 gene. Stem Cell Res. 2021;51:102162.
Yang X, Duan C, Zhang H, Li Y, Guan J, Wang D, Lv Y, Gai Z, Liu Y. Establishment of a non-integrate iPS cell line (SDQLCHi023-A) from a patient with Xq25 microduplication syndrome carrying a 1.3 Mb hemizygote duplication at chrXq25. Stem Cell Res. 2020;51:102147.
Wang L, Zeng Q, Wang S, Wu D, Wang J, Zhang H, Lv X. Establishment of an induced pluripotent stem cell line (SDCHi001-A) from a healthy Chinese child donor. Stem Cell Res. 2023;74:103278.
Xi Y, Zhang H, Wang B, Song W, Liu Y. Establishment of an induced pluripotent stem cell line SDQLCHi049-A from a healthy male neonate. Stem Cell Res. 2023;69:103097.
Xi Y, Zhang H, Yang X, Ai D, Liu Y, Song W. Establishment of induced pluripotent stem cell line SDPHi003-A from a healthy male donor. Stem Cell Res. 2023;71:103160.
Zhang H, Zhang H, Ma Y, Lv Y, Gai Z, Liu Y. Generation and characterization of an induced pluripotent stem cell line SDQLCHi018-A from a congenital myasthenic syndrome patient carrying compound heterozygote mutations in RAPSN gene. Stem Cell Res. 2021;51:102160.
Yang X, Fan Y, Li Y, Zhang H, Wang B, Guan J, Gao J, Ma X, Liu Y. Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi050-A from a healthy donor. Stem Cell Res. 2023;74:103266.
Guan J, Li Z, Zhang H, Yang X, Ma Y, Li Y, Dong R, Gai Z, Liu Y. Generation of a Human iPSC line (SDQLCHi021-A) from a patient with methylmalonic acidemia cblC type carrying compound heterozygous mutations in MMAHC gene. Stem Cell Res. 2020;43:101709.
Wang Y, Yang X, Zhang H, Liu N, Liu Y, Gai Z, Liu Y, Lv Y. Generation of a transgene-free iPS cell line (SDQLCHi053-A) from a young girl carrying a heterozygous mutation (c.427C > T) in SYNGAP1 gene. Stem Cell Res. 2023;71:103132.
Zhang H, Ma Y, Song F, Yang X, Li Y, Guan J, Lv Y, Gao M, Ma J, Liu Y, et al. Generation of an induced pluripotent stem cell line (SDQLCHi003-a) from a patient with short rib-thoracic dysplasia syndrome type III carrying compound heterozygous mutations in DYNC2H1. Stem Cell Res. 2019;39:101505.
Yang X, Zhou T, Zhang H, Li Y, Dong R, Liu N, Pan G, Liu Y, Gai Z. Generation of an induced pluripotent stem cell line (SDQLCHi008-A) from a patient with ASD and DD carrying an 830 kb de novo deletion at chr7q11.22 including the exon 1 of AUTS2 gene. Stem Cell Res. 2019;40:101557.
Zhang H, Liu C, Ma Y, Lin L, Lv Y, Gao M, Gai Z, Liu Y. Generation of an induced pluripotent stem cell line SDQLCHi026-A from a hereditary tyrosinemia type I patient carrying compound heterozygote mutations in FAH gene. Stem Cell Res. 2021;53:102331.
Li Y, Zhang H, Guan J, Wang B, Zhang H, Liu Y, Gai Z. Generation of an iPSC line (SDQLCHi030-A) derived from PBMCs of a patient with Lesch-Nyhan syndrome caused by HPRT1 mutation. Stem Cell Res. 2023;74:103287.
Li Y, Wan Z, Wang B, Zhang H, Guan J, Yang X, Jin X, Ma X, Liu Y. Generation of JAG1 gene c.1615C > T heterozygous mutation human embryonic stem cell line (SDQLCHe001-A) using cytosine base editor. Stem Cell Res. 2023;70:103120.
Ma Y, Zhang H, Yang X, Li Y, Guan J, Zhang K, Huang Y, Pan G, Gai Z, Liu Y. Generation of two induced pluripotent stem cell lines from patients with unbalanced translocation (3;22). Stem Cell Res. 2019;40:101545.
Jia X, Liao N, Yu S, Li H, Liu H, Zhang H, Xu J, Yao Y, He H, Yu G, et al. Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission. Cancer Med. 2024;13(4):e7074.
Zuo R, Liu J, Zhang Y, Zhang H, Li J, Wu J, Ji Y, Mao S, Li C, Zhou Y, et al. In situ regeneration of bone-to-tendon structures: Comparisons between costal-cartilage derived stem cells and BMSCs in the rat model. Acta Biomater. 2022.
Li Y, Zhang H, Yan B, Ma Y, Yang X, Guan J, Lv Y, Gao M, Ma J, Gai Z, et al. An induced pluripotent stem cell line (SDQLCHi006-A) derived from a patient with maple syrup urine disease type Ib carrying compound heterozygous mutations of p.R168C and p.T322I in BCKDHB gene. Stem Cell Res. 2019;40:101579.
Yang X, Liu Y, Zhou T, Zhang H, Dong R, Li Y, Liu N, Liu Y, Gai Z. An induced pluripotent stem cells line (SDQLCHi014-A) derived from urine cells of a patient with ASD and hyperactivity carrying a 303 kb de novo deletion at chr3p26.1 implicating GRM7 gene. Stem Cell Res. 2019;41:101635.
Zhang H, Ma Y, Li X, Yang X, Li Y, Guan J, Dong R, Gai Z, Liu Y. An integration-free iPSC line (SDQLCHi013-A) derived from a patient with maple syrup urine disease carrying compound heterozygote mutations in BCKDHA gene. Stem Cell Res. 2019;41:101585.

Pages